Presentation TCT 2022 Three-Year Outcomes of the Randomized SCOPE I Trial Comparing the ACURATE Neo vs the SAPIEN 3 Transcatheter Heart Valve System in Patients With Symptomatic Severe Aortic Stenosis Presenter: Jonas Lanz September 17, 2022
News Conference News TCT 2021 iFR Matches FFR Through 5 Years: iFR-SWEDEHEART Caitlin E. Cox November 04, 2021
News Conference News TCT 2020 Acurate Neo Still Falls Short of Sapien 3 in SCOPE 1-Year Follow-up Michael O'Riordan October 23, 2020
News Conference News TCT 2020 Acurate Neo Fails to Match Results of CoreValve Evolut: SCOPE 2 Michael O'Riordan October 15, 2020
Presentation TCT 2020 Comparison of self-expanding bioprostheses for transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis: the SCOPE II randomised clinical trial Presenter: Corrado Tamburino October 15, 2020
News Opinion Editor's Corner TCT 2020 TCT 2020: Short DAPT, Longer TAVR Outcomes, Intravascular Imaging, and More Shelley Wood October 09, 2020
News Conference News TCT 2019 SCOPE I: Acurate Neo Comes Up Short for Severe Aortic Stenosis Marcus A. Banks September 27, 2019
Presentation TCT 2019 SCOPE I: A Randomized Trial of the ACURATE Neo vs. the SAPIEN 3 Bioprosthesis in Patients With Severe Aortic Stenosis Presenter: Jonas Lanz September 27, 2019
News Conference News TCT 2019 TCT 2019: Pharmacotherapy in PCI, Head-to-Head Valves, YouTube Rappers, and More Shelley Wood September 19, 2019
Presentation TCT 2017 Underutilization of TAVR in Minority Populations: Scope, Etiologies, and Possible Solutions Presenter: Eberhard Grube, James B. Hermiller Jr., Oluseun Alli November 01, 2017
Presentation TCT 2014 Left Main Stent Thrombosis: New Insights Into the Scope of the Problem Presenter: Davide Capodanno, Evald H. Christiansen, R. Stefan Kiesz, Patrick W. Serruys September 16, 2014